OXYTROL FOR WOMEN OTC
Generic Name and Formulations:
Oxybutynin 3.9mg/day; transdermal patch.
Merck Consumer Care, Inc.
Indications for OXYTROL FOR WOMEN:
Overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
≥18yrs: Apply to clean, dry and smooth area on the abdomen, hips, or buttocks. Use 1 patch for 4 days in a row. Remove patch after 4 days and apply new one. Rotate application sites. Dispose properly with sticky sides together.
<18yrs: not recommended.
Male patients. Pain or burning when urinating. Blood in urine. Unexplained lower back or side pain. Cloudy or foul-smelling urine. Stress incontinence. Urinary or gastric retention. Glaucoma.
Consider other causes of frequent urination (eg, UTI, diabetes, early pregnancy). Unexplained weight loss. Hepatic or renal impairment. Reevaluate if condition worsens or no improvement after 2 weeks. Nursing mothers.
Additive effects with alcohol, other anticholinergic drugs. Caution with antibiotics (eg, erythromycin, clarithromycin) or antifungals (eg, ketoconazole, itraconazole).
Local reactions (eg, itching, rash, redness), sleepiness, dizziness, blurry vision.
Endocrinology Advisor Articles
- FDA Approves Marketing of 2 Devices to Detect Parathyroid Tissue in Real Time
- Long-Term Efficacy and Safety of Dapagliflozin for Type 1 Diabetes
- Diabetes Education Week 2018: Patient Resources for Your Practice
- Cardiometabolic Disease Patterns Related to Race, Ethnicity in Midlife Women
- AHA, ADA Announce Joint Education Initiative to Reduce CVD Deaths in T2D